Publications

Found 230 results
2014
Brosius FC, Coward RJ.  2014.  Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.. Adv Chronic Kidney Dis. 21(3):304-10.
Potla U, Ni J, Vadaparampil J, Yang G, Leventhal JS, Campbell KN, Chuang PY, Morozov A, He JC, D'Agati VD et al..  2014.  Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.. J Clin Invest. 124(4):1757-69.
Udager AM, Prakash A, Saenz DA, Schinke M, Moriguchi T, Jay PY, Lim K-C, Engel JDouglas, Gumucio DL.  2014.  Proper development of the outer longitudinal smooth muscle of the mouse pylorus requires Nkx2-5 and Gata3.. Gastroenterology. 146(1):157-165.e10.
Betz B, Conway BR.  2014.  Recent advances in animal models of diabetic nephropathy.. Nephron Exp Nephrol. 126(4):191-5.
Yamazaki H, Suzuki M, Otsuki A, Shimizu R, Bresnick EH, Engel JDouglas, Yamamoto M.  2014.  A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression.. Cancer Cell. 25(4):415-27.
Dessapt-Baradez C, Woolf AS, White KE, Pan J, Huang JL, Hayward AA, Price KL, Kolatsi-Joannou M, Locatelli M, Diennet M et al..  2014.  Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.. J Am Soc Nephrol. 25(1):33-42.
Fan Y, Wei C, Xiao W, Zhang W, Wang N, Chuang PY, He JCijiang.  2014.  Temporal profile of the renal transcriptome of HIV-1 transgenic mice during disease progression.. PLoS One. 9(3):e93019.
Tampe B, Tampe D, Müller CA, Sugimoto H, LeBleu V, Xu X, Müller GA, Zeisberg EM, Kalluri R, Zeisberg M.  2014.  Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis.. J Am Soc Nephrol. 25(5):905-12.
Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J et al..  2014.  Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.. Kidney Int. 85(5):1214-24.
2013
Ashraf S, Gee HYung, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C et al..  2013.  ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.. J Clin Invest. 123(12):5179-89.
Gee HYung, Saisawat P, Ashraf S, Hurd TW, Vega-Warner V, Fang H, Beck BB, Gribouval O, Zhou W, Diaz KA et al..  2013.  ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.. J Clin Invest. 123(8):3243-53.
Sandholm N, McKnight AJayne, Salem RM, Brennan EP, Forsblom C, Harjutsalo V, Mäkinen V-P, McKay GJ, Sadlier DM, Williams WW et al..  2013.  Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.. J Am Soc Nephrol. 24(10):1537-43.
Bethunaickan R, Berthier CC, Zhang W, Kretzler M, Davidson A.  2013.  Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.. PLoS One. 8(10):e77489.
Merscher-Gomez S, Guzman J, Pedigo CE, Lehto M, Aguillon-Prada R, Mendez A, Lassenius MI, Forsblom C, Yoo T, Villarreal R et al..  2013.  Cyclodextrin protects podocytes in diabetic kidney disease.. Diabetes. 62(11):3817-27.
Ju W, Greene CS, Eichinger F, Nair V, Hodgin JB, Bitzer M, Lee Y-S, Zhu Q, Kehata M, Li M et al..  2013.  Defining cell-type specificity at the transcriptional level in human disease.. Genome Res. 23(11):1862-73.
Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PXK, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ et al..  2013.  Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.. Kidney Int. 83(4):749-56.
Suzuki M, Yamazaki H, Mukai HY, Motohashi H, Shi L, Tanabe O, Engel JDouglas, Yamamoto M.  2013.  Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model.. Mol Cell Biol. 33(8):1687-95.
Blattner SM, Hodgin JB, Nishio M, Wylie SA, Saha J, Soofi AA, Vining C, Randolph A, Herbach N, Wanke R et al..  2013.  Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.. Kidney Int. 84(5):920-30.
Mallipattu SK, Liu R, Zhong Y, Chen EY, D'Agati V, Kaufman L, Ma'ayan A, Klotman PE, Chuang PY, He JC.  2013.  Expression of HIV transgene aggravates kidney injury in diabetic mice.. Kidney Int. 83(4):626-34.
Sanchez-Niño MDolores, Poveda J, Sanz ABelen, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB et al..  2013.  Fn14 in podocytes and proteinuric kidney disease.. Biochim Biophys Acta. 1832(12):2232-43.
Pesce F, Pathan S, Schena FPaolo.  2013.  From -omics to personalized medicine in nephrology: integration is the key.. Nephrol Dial Transplant. 28(1):24-8.
Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, E Weil J, Pezzolesi MG, Krolewski AS, Randolph A, Keller BJ et al..  2013.  From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy.. Diabetes. 62(7):2605-12.
Sampson MG, Gillies CE, Ju W, Kretzler M, Kang HMin.  2013.  Gene-level integrated metric of negative selection (GIMS) prioritizes candidate genes for nephrotic syndrome.. PLoS One. 8(11):e81062.
Sampson MG, Jüppner H.  2013.  Genes, Exomes, Genomes, Copy Number: What is Their Future in Pediatric Renal Disease.. Curr Pediatr Rep. 1(1):52-59.
Brennan E, McEvoy C, Sadlier D, Godson C, Martin F.  2013.  The genetics of diabetic nephropathy.. Genes (Basel). 4(4):596-619.

Pages